Accelerate Diagnostics Cash Flow - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$26.6 $1.85 (7.47%) AXDX stock closing price Feb 24, 2017 (Closing)

The Accelerate Diagnostics cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Accelerate Diagnostics profits and Accelerate Diagnostics debt. Accelerate Diagnostics stock analysis shows negative net income cash flow of $-50.23M for 2016-Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   AXDX increase in investments stood at a negative value of $-52.21M for the latest 2016-Q3. View details of Accelerate Diagnostics cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Accelerate Diagnostics Net Income Cash Flow
-50.23M-32.94M-15.07M-45.49M-32.33M-21.14M-8.89M-30.93M-22.16M-13.35M
Depreciation Depletion Amortization Cash-Flow2M1.27M0.58M1.98M1.34M0.83M0.37M1.15M0.82M0.44M
Net Increase (Decrease) in Assets Liabilities1.12M-0.25M-0.39M--0.24M-0.22M-0.09M1.36M0.01M0.17M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net6.5M3.83M1.68M8.38M5.99M4.18M1.65M9.62M7.33M4.93M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
-40.6M-28.08M-13.2M-35.12M-25.24M-16.35M-6.96M-18.78M-13.99M-7.8M
Increase (Decrease) in Prop Plant And Equipment-2.3M-2.08M-1.68M-3.65M-2.59M-2.16M-1.19M-1.93M-1.35M-0.72M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-49.91M-53.15M-32.81M0.98M-0.97M-0.06M1.95M-1.43M-2.36M-1.95M
Other Cash Inflow (Outflow) from Investment Activities----------
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
-52.21M-55.23M-34.49M-2.67M-3.56M-2.22M0.76M-3.37M-3.71M-2.68M
Issuance (Purchase) of Equity Shares0.94M0.09M0.02M104.97M0.54M0.32M0.06M45.79M45.6M45.71M
Issuance (Repayment) of Debt Securities-0.01M-0.01M-0.01M-0.14M-0.11M-0.07M-0.03M-0.1M-0.07M-0.03M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities0.05M0.17M-0.81M-------
Accelerate Diagnostics Net Cash from (used by) Financing Activities
0.98M0.25M-0.79M104.82M0.43M0.25M0.03M45.69M45.53M45.67M
Effect of Exchange Rate Changes on Cash-0.01M--0.04M-------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
-91.85M-83.06M-48.55M67.02M-28.37M-18.33M-6.17M23.53M27.82M35.18M
Cash & Equivalents at Beginning of Year53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M3M
Cash & Equivalents at Year End28.73M37.51M72.03M120.58M25.19M35.23M47.39M53.56M57.85M65.21M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

1:25
AXDX
While Accelerate Diagnostics stock price history provides the price history of a stock, Accelerate Diagnostics stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Net Change in Cash and Cash Equivalents: Accelerate Diagnostics cash reduced QoQ to $-50.23M, meaning the company is unable to meet its expenditure and grow cash which will also eventually reflect in the Accelerate Diagnostics stock price movement.
  • Accelerate Diagnostics decreased its cash from operating activities to $12.52M in 2016-Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: Accelerate Diagnostics generated $3.02M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Accelerate Diagnostics earned $0.73M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.
.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin
-637